ProAxsis specialises in the development and commercialisation of in vitro diagnostic laboratory assays and point–of–care tests designed to measure active protease biomarkers of disease.
Kainos Group plc is a UK–headquartered provider of Digital Services and Digital Platforms.
Causeway Sensors are revolutionising the discovery and development of biotherapeutics using label–free plasmonic nanostructures